| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Genentech Cpd 10 | GDSC1000 | pan-cancer | AAC | -0.074 | 0.02 |
| mRNA | BEC | CTRPv2 | pan-cancer | AAC | 0.16 | 0.02 |
| mRNA | ML162 | CTRPv2 | pan-cancer | AAC | 0.079 | 0.03 |
| mRNA | tivozanib | GDSC1000 | pan-cancer | AAC | -0.081 | 0.03 |
| mRNA | YM201636 | GDSC1000 | pan-cancer | AAC | -0.073 | 0.03 |
| mRNA | masitinib | GDSC1000 | pan-cancer | AAC | -0.076 | 0.03 |
| mRNA | barasertib | CTRPv2 | pan-cancer | AAC | -0.074 | 0.03 |
| mRNA | Crizotinib | GDSC1000 | pan-cancer | AAC | -0.12 | 0.03 |
| mRNA | JW-74 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.03 |
| mRNA | avicin D | CTRPv2 | pan-cancer | AAC | 0.13 | 0.03 |